Curated from medtech publications. Product launches, FDA clearances, M&A, technology shifts — rewritten as short briefs, linked back to the source. Filter by theme below.
Forus, an AI-powered diagnostic imaging software company, raised $150 million in Series C funding led by Bain Capital Ventures, valuing the company at $3 billion. The round included participation from Thrive Capital, General Catalyst, Accel, Redpoint, and eight other venture firms.
OncoSil Medical has secured A$5.6 million ($4.03 million) in funding commitments to support the launch of its single-use brachytherapy device for cancer treatment. The capital raise will enable commercialization of the device.
Boston Scientific experienced a cyberattack on August 25 that disrupted global operations. The company is now in recovery mode following the incident. No details on impact scope, systems affected, or timeline to full restoration were provided.
The House VA Committee voted unanimously to subpoena Oracle Health executives Larry Ellison and Mike Sicilia after the Department of Veterans Affairs electronic health record contract swelled from $10 billion to $27 billion. Oracle had previously pledged to Congress it would cover overages beyond the original cap. The cost escalation has triggered congressional scrutiny of the vendor's accountability and contract performance.
Intravascular lithotripsy (IVL) adoption is increasing in interventional cardiology, though widespread implementation remains limited by practical constraints. The trend reflects growing clinical acceptance, but standardization and consistency across centers will determine whether IVL becomes routine practice.
Elucid announced a $55 million funding round to accelerate commercial expansion of its cardiovascular diagnostic platform, including its Plaque-IQ diagnostic tool. The proceeds will support scaling of the clinical platform serving cardiologists and related specialists.
PixCell Medical has partnered with Inter Medico to distribute its HemoScreen haematology analyser across Canada. The deal expands PixCell's geographic footprint into the Canadian market through a regional distributor agreement.
Flosonics Medical received a $70 million BARDA contract to develop FloPredict, an AI algorithm designed to support trauma care and mass casualty event response. The contract funds advancement of the company's wearable technology platform for emergency and critical care applications.
Medtronic raised its fiscal 2027 outlook following strong first-quarter results, with cardiac ablation solutions delivering 29.5% year-over-year growth as the electrophysiology business's top performer. The company's positive guidance reflects momentum across its portfolio segments.
Scan.com raised $220 million in combined equity and debt financing to expand its US medical imaging network. The funding will support the company's growth in diagnostic imaging services and infrastructure across the country.
Kardium secured up to $22.5 million in funding from the Government of Canada to support manufacturing of its Globe Pulsed Field System in British Columbia. The pulsed field ablation technology is used for cardiac arrhythmia treatment. The funding backs production capacity expansion for the minimally invasive cardiac device.
Boston Scientific disclosed a cyberattack discovered on 25 August that has caused global operational disruptions. The incident affects the medical device supplier's IT systems and poses supply-chain risks to customers and distributors relying on the company's ordering, fulfillment, and support infrastructure.
PENTAX Medical has expanded its partnership with MAGENTIQ EYE to accelerate global deployment of AI-assisted colonoscopy technology. The collaboration aims to increase adoption of AI-enabled diagnostic capabilities across PENTAX's endoscopy portfolio in international markets.
Onos Health closed a $17M Series A funding round led by Costanoa, with participation from Flare Capital Partners and CVS Health Ventures. The funding will support expansion of the company's AI-powered behavioral health platform.
Boston Scientific disclosed a cyberattack affecting its global IT systems and order-fulfillment capabilities, with no timeline given for service restoration. The incident marks the latest major breach to hit a tier-one medtech vendor in 2026, following similar attacks on Stryker, Medtronic, and Abbott. Supply chain disruptions and operational impacts remain uncertain pending system recovery.
Hike Medical secured $22.5 million in funding to enhance its platform for clinician ordering workflows in durable medical equipment and orthotics supply. The capital will support technology development aimed at accelerating patient delivery timelines in the DME and orthotic space.
IceCure Medical has signed an exclusive distribution agreement with Scovas Medical to supply ProSense cryoablation systems in the Netherlands. The deal expands IceCure's market reach in the region through a specialized distributor partner.
Private equity investment in medical device manufacturers and suppliers is accelerating as investors seek higher returns than public markets offer. The trend affects OEM profitability, operational strategy, and workforce dynamics across the medtech supply chain, reshaping vendor consolidation and competitive positioning.
Smith+Nephew announced a five-year partnership with Imperial College London to establish a research center focused on musculoskeletal robotic surgery. The collaboration will combine the company's expertise with academic research to co-develop new robotic surgical solutions, marking the first such partnership for both organizations in this domain.
Shape Memory Medical closed a $10 million funding round led by August Global Partners to advance clinical trials for its aortic device portfolio. The financing supports the company's development of cardiovascular interventions targeting aortic pathology.
MaxQ Medical, backed by Olympus, raised $31.5 million to advance its integrated prostate care platform that combines imaging with tissue-selective therapy in a single transurethral procedure. The funding supports continued development and commercialization of the technology, which addresses minimally invasive treatment of benign prostatic hyperplasia and related conditions.
Renata Medical raised $25 million in funding to advance Minima, a pediatric stent system designed for congenital heart defects in children. The capital will support continued development and commercialization of the device.
Happy Health secured $75 million in funding from ARCH Venture Partners and OpenLoop to expand home-based care operations. The round supports the company's growth in delivering medical services and support to patients in home settings.
Perimeter and Culturewell have launched a joint hospital infection surveillance programme that combines room-level surface sampling with building-level wastewater sequencing. The partnership pairs each company's diagnostic and monitoring capabilities to offer hospitals integrated pathogen detection across environmental and waste streams.
Happy Health, whose smart ring received FDA clearance in September 2024 for obstructive sleep apnea diagnosis, has raised $75 million to expand its continuous healthcare platform. The funding will support broader development and commercialization of the wearable device and related analytics capabilities.
Qosina, a medical device component supplier, has launched regulatory services for device developers and manufacturers. The new offering addresses compliance challenges arising from unexpected supply chain changes and material substitutions, according to CEO Lee Pochter. The service expands Qosina's traditional role as a supplier into consulting and regulatory support.
4DMedical and Azra AI have formed a partnership to provide integrated lung care management solutions for health institutions. The collaboration combines 4DMedical's imaging technology with Azra AI's diagnostic software to enable end-to-end lung disease detection and monitoring across clinical workflows.
Olympus has signed a global distribution agreement for Endocision's cryocatheter, with commercial launch planned in the US, Canada, and Europe starting in early 2027. The deal expands Olympus's portfolio in minimally invasive surgical tools and represents a significant partnership in the cryotherapy device space.
Zeus has leased a new catheter manufacturing facility for its CathX Medical subsidiary in Costa Rica's La Lima Free Zone. The expansion supports long-term customer demand as programs transition from development to commercialization, according to CEO Paddy O'Brien.
Bridge to Life secured $110 million in funding to support US commercialization of its VitaSmart liver perfusion system, expand its product portfolio, and scale global operations. The capital will accelerate market entry and broader international deployment of the organ perfusion technology.
Abbott and Google Health announced a partnership to integrate continuous glucose monitoring with AI-driven health guidance within Google Health's platform. The collaboration combines Abbott's monitoring hardware with Google's software and AI capabilities to deliver glucose data and personalized insights to users.
Alcon reported strong Q2 results and raised its 2026 earnings growth outlook. The surgical segment generated approximately $1.6 billion in revenue, representing 8% year-over-year growth and accounting for the largest share of company profits.
Teledyne Technologies agreed to acquire Varex Imaging for approximately $1.1 billion in an all-cash transaction. Varex, a supplier of X-ray imaging components and subsystems used in medical, industrial, and security applications, becomes part of Teledyne's portfolio. The deal expands Teledyne's presence in medical imaging technology and component supply.
ResMed's stock declined 7% following the company's cautious FY27 guidance. The manufacturer cited suspended ventilator sales and macroeconomic uncertainty as headwinds affecting its outlook. The ventilator suspension signals potential supply-chain or regulatory constraints impacting a key product line.
Hinge Health acquired Cylinder to expand into gastrointestinal care offerings. The deal represents a strategic move into a new clinical domain, though industry observers are divided on whether employers will prioritize the convenience of an integrated platform over specialized standalone solutions for GI diagnostics and treatment.
iRhythm Technologies acquired VitalConnect for $287.5 million, expanding its cardiac monitoring portfolio. The deal was announced alongside iRhythm's Q2 results, which showed revenue growth of 20.1% year-over-year. VitalConnect's wearable monitoring technology complements iRhythm's existing cardiac diagnostic capabilities.
Philips announced six new partnerships aimed at expanding its patient monitoring ecosystem, particularly for out-of-hospital monitoring capabilities. The partnerships are designed to broaden Philips' reach and integration options in remote patient monitoring and connected care delivery.
Azra AI and Blackford announced a partnership to integrate imaging-based AI detection with care coordination workflows for patients with complex or urgent conditions. The partnership aims to bridge diagnostic imaging AI output with downstream clinical care management systems, enabling better handoff and coordination between detection and treatment planning.
Zimmer Biomet reported 4.8% year-over-year revenue growth in Q2 and raised its 2026 financial outlook, driving a 5% share price increase at NYSE opening on August 5. The earnings beat reflects demand across the company's orthopedics, spine, and specialty surgical portfolios.
Wellinks raised $10 million in Series B funding to advance its remote patient monitoring platform for respiratory disease management. The round included participation from UMass Memorial Health, building on an existing relationship. The funding will support continued development of the RPM tool for chronic respiratory conditions.
168 older market stories available.